Astraeus Ventures backs founders building at the seams of frontier technology, human longevity, and a livable planet — with patient capital, decade-long horizons, and a refusal to confuse motion for progress.
We invest the way a gardener plants an orchard. Slowly. With patience for seasons we cannot rush and respect for soil we did not make.
Astraeus was the Greek god of dusk and the wandering stars. We borrowed the name because we believe the most important companies of the next decade will look ordinary at the hour they are founded — and luminous only in retrospect.
We write checks from $500K to $8M, lead or follow, hold for a decade or longer, and stay close enough to be useful without being noisy. Read the full thesis →
Local inference, model compression, vertical agents, and the picks-and-shovels of an industry growing faster than capital can responsibly chase.
Diagnostics, therapeutics, and consumer products targeting healthspan, metabolic health, and the slow undoing of aging at the cellular level.
Grid-scale storage, geothermal, fusion-adjacent, atmospheric carbon, and the unglamorous logistics of moving electrons through aging infrastructure.
Programmable cells, novel materials, and the industrialization of biology as a manufacturing substrate — from leather to lithium binders.
Foundation models given hands. We back the actuators, simulators, and vertical operators that translate language into useful physical work.
The slow defection from the food and beverage industrial complex. Brands and software that make health legible and unembarrassing to buy.
Every application is read by a partner. No junior screening, no template responses, no ghosting.